 Kathryn Chatfield
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Noonan Syndrome | 5 | 2022 | 14 | 2.320 |
Why?
| | Cardiolipins | 4 | 2025 | 82 | 1.390 |
Why?
| | Cardiomyopathies | 7 | 2025 | 337 | 1.350 |
Why?
| | Heart Transplantation | 4 | 2026 | 736 | 0.970 |
Why?
| | Barth Syndrome | 2 | 2021 | 9 | 0.880 |
Why?
| | Electron Transport Complex I | 2 | 2021 | 42 | 0.820 |
Why?
| | Myocardium | 6 | 2025 | 939 | 0.780 |
Why?
| | Williams Syndrome | 2 | 2021 | 13 | 0.730 |
Why?
| | Mitochondria, Heart | 3 | 2020 | 102 | 0.700 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2026 | 359 | 0.680 |
Why?
| | Turner Syndrome | 4 | 2025 | 63 | 0.670 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 2025 | 20 | 0.660 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2021 | 25 | 0.660 |
Why?
| | ras Proteins | 5 | 2026 | 150 | 0.650 |
Why?
| | Fatty Acids | 3 | 2025 | 450 | 0.640 |
Why?
| | General Practice | 1 | 2019 | 32 | 0.590 |
Why?
| | Cardiomyopathy, Hypertrophic | 4 | 2023 | 145 | 0.590 |
Why?
| | Alagille Syndrome | 1 | 2018 | 29 | 0.560 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 72 | 0.560 |
Why?
| | Heart Defects, Congenital | 5 | 2025 | 913 | 0.560 |
Why?
| | DNA, Mitochondrial | 2 | 2020 | 210 | 0.530 |
Why?
| | Mutation | 10 | 2026 | 4085 | 0.510 |
Why?
| | Costello Syndrome | 3 | 2023 | 3 | 0.490 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.440 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.440 |
Why?
| | Heart Ventricles | 2 | 2020 | 756 | 0.400 |
Why?
| | Heart Failure | 2 | 2019 | 2314 | 0.390 |
Why?
| | Mitochondria | 2 | 2021 | 983 | 0.380 |
Why?
| | De Lange Syndrome | 1 | 2012 | 2 | 0.380 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2021 | 22 | 0.360 |
Why?
| | Pyrimidinones | 2 | 2023 | 126 | 0.350 |
Why?
| | Infant | 12 | 2024 | 10022 | 0.350 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 45 | 0.330 |
Why?
| | Pyridones | 2 | 2023 | 198 | 0.330 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2192 | 0.330 |
Why?
| | Genetic Association Studies | 1 | 2012 | 372 | 0.330 |
Why?
| | Mydriasis | 2 | 2022 | 10 | 0.320 |
Why?
| | Child | 17 | 2026 | 22537 | 0.310 |
Why?
| | Child, Preschool | 8 | 2021 | 11774 | 0.290 |
Why?
| | Energy Metabolism | 1 | 2015 | 935 | 0.280 |
Why?
| | Humans | 41 | 2026 | 144261 | 0.280 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1495 | 0.270 |
Why?
| | Chromosome Disorders | 2 | 2021 | 45 | 0.270 |
Why?
| | Acyltransferases | 3 | 2025 | 78 | 0.270 |
Why?
| | Phenotype | 4 | 2021 | 3157 | 0.240 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 2111 | 0.240 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2026 | 14 | 0.240 |
Why?
| | Female | 24 | 2026 | 77976 | 0.230 |
Why?
| | Male | 21 | 2026 | 72035 | 0.230 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 1 | 2025 | 3 | 0.230 |
Why?
| | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase | 1 | 2025 | 3 | 0.230 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2025 | 5 | 0.230 |
Why?
| | Purpura | 1 | 2025 | 18 | 0.230 |
Why?
| | Heart Valve Diseases | 2 | 2024 | 151 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 128 | 0.220 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2022 | 46 | 0.220 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Niacinamide | 1 | 2024 | 86 | 0.200 |
Why?
| | Aortic Valve | 2 | 2024 | 360 | 0.200 |
Why?
| | Ectodermal Dysplasia | 1 | 2022 | 19 | 0.190 |
Why?
| | Infant, Newborn | 8 | 2026 | 6424 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 2019 | 45 | 0.190 |
Why?
| | Stress, Mechanical | 1 | 2024 | 494 | 0.180 |
Why?
| | Regional Blood Flow | 1 | 2024 | 512 | 0.180 |
Why?
| | Face | 2 | 2020 | 173 | 0.180 |
Why?
| | Gene Expression | 3 | 2018 | 1487 | 0.170 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 118 | 0.170 |
Why?
| | Hemodynamics | 2 | 2024 | 1119 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 219 | 0.170 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 8 | 0.170 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 13 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 253 | 0.170 |
Why?
| | Anesthetics | 1 | 2022 | 99 | 0.170 |
Why?
| | Genetic Testing | 2 | 2021 | 478 | 0.170 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 1084 | 0.160 |
Why?
| | Fetal Diseases | 1 | 2022 | 191 | 0.160 |
Why?
| | Coenzyme A | 1 | 2020 | 7 | 0.160 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 76 | 0.160 |
Why?
| | Urinary Bladder | 1 | 2022 | 194 | 0.160 |
Why?
| | Aorta | 2 | 2024 | 429 | 0.160 |
Why?
| | Heart-Assist Devices | 1 | 2026 | 567 | 0.160 |
Why?
| | Biological Products | 1 | 2023 | 251 | 0.160 |
Why?
| | Echocardiography | 2 | 2024 | 647 | 0.150 |
Why?
| | Actins | 2 | 2022 | 422 | 0.150 |
Why?
| | Genes, ras | 1 | 2019 | 96 | 0.150 |
Why?
| | Electron Transport | 2 | 2020 | 118 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 304 | 0.150 |
Why?
| | Intellectual Disability | 1 | 2021 | 174 | 0.150 |
Why?
| | Calcium | 2 | 2022 | 1182 | 0.140 |
Why?
| | Galactosyltransferases | 1 | 2018 | 12 | 0.140 |
Why?
| | Nitrogenous Group Transferases | 1 | 2018 | 2 | 0.140 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2018 | 17 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 297 | 0.140 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2018 | 4 | 0.140 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 16 | 0.140 |
Why?
| | Adolescent | 8 | 2026 | 22281 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2018 | 46 | 0.140 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 375 | 0.140 |
Why?
| | Postoperative Period | 1 | 2019 | 353 | 0.140 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 15 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 276 | 0.130 |
Why?
| | Protein Subunits | 1 | 2018 | 226 | 0.130 |
Why?
| | Mitochondrial Diseases | 1 | 2018 | 93 | 0.130 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 275 | 0.130 |
Why?
| | Constriction, Pathologic | 1 | 2018 | 248 | 0.130 |
Why?
| | Retrospective Studies | 5 | 2026 | 17009 | 0.130 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 197 | 0.130 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 50 | 0.130 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 10 | 0.130 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 20 | 0.130 |
Why?
| | Seizures | 1 | 2021 | 460 | 0.130 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 195 | 0.120 |
Why?
| | Case-Control Studies | 2 | 2021 | 3592 | 0.120 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 551 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 582 | 0.120 |
Why?
| | Muscle, Smooth | 3 | 2022 | 151 | 0.120 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2018 | 139 | 0.120 |
Why?
| | Genetic Diseases, Inborn | 1 | 2016 | 44 | 0.120 |
Why?
| | Emotions | 1 | 2021 | 577 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 31 | 0.110 |
Why?
| | Heart | 1 | 2019 | 633 | 0.110 |
Why?
| | Registries | 2 | 2026 | 2382 | 0.110 |
Why?
| | Dyskinesias | 1 | 2015 | 20 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2016 | 292 | 0.110 |
Why?
| | Cell Respiration | 1 | 2015 | 107 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1646 | 0.100 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.100 |
Why?
| | Prevalence | 1 | 2021 | 2815 | 0.100 |
Why?
| | Vascular Stiffness | 1 | 2018 | 462 | 0.100 |
Why?
| | Muscles | 1 | 2015 | 333 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2359 | 0.100 |
Why?
| | Fibroblasts | 2 | 2018 | 1032 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 2048 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2025 | 2134 | 0.090 |
Why?
| | Chondroitin Sulfate Proteoglycans | 1 | 2012 | 10 | 0.090 |
Why?
| | Age Factors | 2 | 2024 | 3313 | 0.090 |
Why?
| | Parents | 1 | 2021 | 1401 | 0.090 |
Why?
| | Genotype | 2 | 2019 | 1833 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1782 | 0.090 |
Why?
| | Transcription Factors | 1 | 2020 | 1739 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 261 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2020 | 2829 | 0.090 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 132 | 0.090 |
Why?
| | Signal Transduction | 3 | 2023 | 5221 | 0.080 |
Why?
| | Syndrome | 2 | 2022 | 380 | 0.080 |
Why?
| | Genomics | 1 | 2014 | 833 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2026 | 11643 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 628 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6021 | 0.070 |
Why?
| | Disease Management | 2 | 2025 | 643 | 0.070 |
Why?
| | Developmental Disabilities | 2 | 2021 | 281 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1021 | 0.060 |
Why?
| | Pregnancy | 2 | 2018 | 7180 | 0.060 |
Why?
| | Liver | 1 | 2015 | 1884 | 0.060 |
Why?
| | Mice | 5 | 2025 | 18329 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2025 | 10 | 0.060 |
Why?
| | Rhabdomyolysis | 1 | 2025 | 23 | 0.060 |
Why?
| | Dilatation, Pathologic | 1 | 2024 | 62 | 0.050 |
Why?
| | Animals | 6 | 2026 | 38030 | 0.050 |
Why?
| | Perfusion Imaging | 1 | 2024 | 65 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2917 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2026 | 309 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 70 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 20 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2024 | 214 | 0.050 |
Why?
| | Blood Flow Velocity | 1 | 2024 | 413 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2022 | 28 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 390 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2879 | 0.050 |
Why?
| | Duodenum | 1 | 2022 | 77 | 0.050 |
Why?
| | Disulfides | 1 | 2022 | 96 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2024 | 285 | 0.050 |
Why?
| | Nervous System Diseases | 1 | 2025 | 282 | 0.040 |
Why?
| | Calcium Channels | 1 | 2022 | 154 | 0.040 |
Why?
| | United States | 1 | 2019 | 15876 | 0.040 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 9 | 0.040 |
Why?
| | Survival Rate | 1 | 2026 | 2088 | 0.040 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2021 | 35 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.040 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 50 | 0.040 |
Why?
| | Skin | 1 | 2026 | 754 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 318 | 0.040 |
Why?
| | Myofibrils | 1 | 2021 | 49 | 0.040 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 225 | 0.040 |
Why?
| | Sarcomeres | 1 | 2021 | 98 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 160 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2021 | 124 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 288 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 498 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 621 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13990 | 0.040 |
Why?
| | SOS1 Protein | 1 | 2018 | 2 | 0.040 |
Why?
| | LEOPARD Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.040 |
Why?
| | Lentivirus | 1 | 2018 | 60 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2020 | 336 | 0.040 |
Why?
| | Digoxin | 1 | 2018 | 27 | 0.040 |
Why?
| | Propranolol | 1 | 2018 | 44 | 0.040 |
Why?
| | Amiodarone | 1 | 2018 | 31 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1134 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 172 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2023 | 2182 | 0.030 |
Why?
| | Adult | 3 | 2018 | 40262 | 0.030 |
Why?
| | Lactoferrin | 1 | 1998 | 36 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2018 | 144 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 210 | 0.030 |
Why?
| | Pedigree | 1 | 2018 | 513 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.030 |
Why?
| | Milk | 1 | 1998 | 119 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1191 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 186 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 1998 | 128 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1559 | 0.030 |
Why?
| | Capital Financing | 1 | 2016 | 7 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 542 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 262 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 286 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 62 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 905 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 360 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2018 | 458 | 0.030 |
Why?
| | Leigh Disease | 1 | 2015 | 22 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 549 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1335 | 0.030 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2014 | 21 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2014 | 33 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 2154 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 315 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 977 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4556 | 0.030 |
Why?
| | Aged | 1 | 2014 | 25850 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 578 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 4146 | 0.020 |
Why?
| | Models, Molecular | 1 | 2018 | 1618 | 0.020 |
Why?
| | Models, Biological | 1 | 2021 | 1820 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2020 | 3119 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1953 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5813 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4254 | 0.020 |
Why?
| | Middle Aged | 1 | 2014 | 35762 | 0.020 |
Why?
| | Mental Disorders | 1 | 2021 | 1138 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5935 | 0.020 |
Why?
| | Family | 1 | 2016 | 679 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2016 | 1050 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2424 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2603 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3857 | 0.010 |
Why?
| | Lactation | 1 | 1998 | 192 | 0.010 |
Why?
| | Iron | 1 | 1998 | 359 | 0.010 |
Why?
|
|
Chatfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|